The Pathogenesis of Systemic Chlamydial Infections: Theoretical Considerations of Host Cell Energy Depletion and Its Metabolic Consequences

Antimicrobics and Infectious Diseases Newsletter

Volumn 16, Issue 5, 1997, Pages 33-38

  Stratton, Charles W ^a   Mitchell, William M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042545194     PISSN: 1069417X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1069-417X(00)80019-9     Document Type: Article

References (41)

1. Babcock GT, Wickström M: Oxygen activation and the conservation of energy in cell respiration. Nature 356:301-309, 1992.
2. Batterspy AR: Biosynthesis of the pigments of life. Proceedings of the Royal Society of London 225:1-26, 1985.
3. Becker Y: The chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes. Microbio Rev 42:247-306, 1978.
4. Bonkowsky HL, Schady W: Neurologic manifestations of acute porphyria. Seminars in Liver Diseases 2:108-124, 1982.
5. Bose SK, Liebhaber H: Deoxyribonuclease acid synthesis, cell cycle progression, and division of Chlamydia-infected HeLa 229 cells. Infect Immun 24:953-957, 1979.
6. Brennan MJW, Cantrill RC, Kramer S: Effect of ∂-aminolevulinic acid on GABA receptor binding in synaptic plasma membranes. Int J Biochem 833-835, 1980.
7. Burgoyne K, Swartz R, Ananth J: Porphyria: reexamination of psychiatric implications. Psychotherapy and Psychosomatics 64:121-131, 1995.
8. Cerutti PA: Prooxidant states and tumor promotion. Science 227:375-381, 1985.
9. Duee ED, Vignais PV: Exchange between extra- and intra-mitochondrial adenine nucleotides. Biochem Biophys Acta 107:184-188, 1965.
10. Ellefson RD: Porphyrinogens, porphyrins, and the porphyrias. Mayo Clinic Proceedings 57:454-458, 1982.
11. Frenkel K: Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacologies and Therapeutics 53:127-166, 1992.
12. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic smooth muscle cells. Infect Immun 64:1614-1620, 1996.
13. Gajdos A: Excess porphyrin formation following administration of inhibitors of the biosynthesis of ATP. Acta Med Scand 446:35-40, 1966.
14. Gibson JB, Goldberg A: The neuropathology of acute porphyria. J Path Bacteriol 71:495-509, 1956.
15. Gill SD, Stewart RB: Respiration of L cells infected with Chlamydia psittaci. Canadian J Microb 16:1033-1039, 1970.
16. Hatch TP, Al-Hossainy E, Silverman JA: Adenine nucleotide and lysine transport in Chlamydia psittaci. J Bacteriol, 150:662-670, 1985.
17. Hindmarsh JT: The porphyrias: recent advances. Clin Chem 32:1255-1263, 1986.
18. Horoschak KD, Moulder JW: Division of single host cells after infection with chlamydiae. Infect Immun 19:281-286, 1978.
19. Kalckar HM: 50 years of biological research - from oxidative phosphorylation to energy transport regulation. Annual Rev Biochem 60:1-37, 1991.
20. Kauppinen R, Mustajoki P: Acute hepatic porhyria and hepatocellular carcinoma. Br J Cancer 57:117-120, 1988.
21. Kordac V: Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up. Neoplasma 19:135-139, 1972.
22. Koul S, Singh J, Dhingra PN, Kharta GS: Studies on experimental mastitis in goat histoenzymology. Comparative Immunology and Microbiology of Infectious Diseases. 16:307-316, 1993.
23. Lehninger AL: The Mitochondrion: Molecular Basis of Structure and Function. The Benjamin Company, Inc., New York, 1990.
24. McClarity G: Chlamydiae and the biochemistry of intracellular parasitism. Microbiol 2:157-164, 1994.
25. Meola T, Lim HW: The porphyrias. Bullous Diseases 11:583-596, 1993.
26. Moore MR: Biochemistry of porphyria. Int J Biochem 1993, 10:1353-1368.
27. Moulder JW, Grisso DL, Brubaker RR: Enzymes of glucose catabolism in a member of the psittacosis group. J Bacteriol 89: 810-812, 1965.
28. Mustajoki P, Tenhunen R: Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity. Eur J Clin Invest 15:281-284, 1985.
29. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson: Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Path 49:102-106, 1996.
30. Ormsbee RA, Weiss E: Trachoma agent: glucose utilization by purified suspensions. Science 1963, 142:1077-1078.
31. 31P nuclear magnetic resonance study of Chlamydia trachomatis: induction of ATPas activity in elementary bodies. Infect Immun 57:3338-3344, 1989.
32. Pedersen PI, Carafoli E: Ion motive ATPases. II. Energy coupling and work output. Trends Biochem Sci 12:145-150, 1987.
33. Pedersen PI, Carafoli E: Ion motive ATPases. I. Ubiquity, properties, and significance to cell function. Trends Biochem Sci 12:145-150, 1987.
34. 1-type ATP synthases and ATPases. Advanced Enzymology and Related Areas in Molecular Biology. 64:173-214, 1991.
35. Senior AE: ATP synthesis by oxidative phosphorylation. Physiol Rev 68:177-231, 1988.
36. Slater EC: The mechanism of the conservation of energy of biological oxidation. Eur J Biochem 166:489-504, 1987.
37. Weiss E: Adenosine triphosphate and other requirements for the utilization of glucose by agents of the psittacosistrachoma group. J Bacteriol 90:243-253, 1965.
38. Weiss E, Kiesow LA: Incomplete citric acid cycle in agents of the psittacosistrachoma group. Bacteriology Proceedings 85, 1966.
39. Weiss E, Myers W, Dressier HR, Chun-Hoon H: Glycose metabolism by agents of the psittacosis-trachoma group. Virology 22:551-562, 1964.
40. Weiss E, Wilson NN: Role of exogenous adenosine triphosphate in catabolic and synthetic activities of Chlamydia psittaci. J Bacteriol 97:719-724, 1969.
41. Yeung Laiwah AA, Rapeport WG, Thomson GG, Machee GJA, Philip MF, Moore MR, Brodie MJ, Goldberg A: Carbamazepine-induced non-hereditary acute porphyria. Lancet i:790-792, 1983.